ArticleInternational journal of molecular sciences2020

Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.

Koh Kitagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.